Related references
Note: Only part of the references are listed.Changing Concepts of Hormone Receptor-Positive Advanced Breast Cancer Therapy
Rowan T. Chlebowski
CLINICAL BREAST CANCER (2013)
Survivin expression and targeting in breast cancer
Kumkum Jha et al.
SURGICAL ONCOLOGY-OXFORD (2012)
Higher Population-Based Incidence Rates of Triple-Negative Breast Cancer Among Young African-American Women Implications for Breast Cancer Screening Recommendations
Kathryn C. Amirikia et al.
CANCER (2011)
MIRA-SNuPE, a quantitative, multiplex method for measuring allele-specific DNA methylation
Dong-Hoon Lee et al.
EPIGENETICS (2011)
Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cells
A. E. Richardson et al.
GROWTH FACTORS (2011)
Differential expression and signaling activation of insulin receptor isoforms A and B: A link between breast cancer and diabetes
S. Kalla Singh et al.
GROWTH FACTORS (2011)
Regulation of IGF2 transcript and protein expression by altered methylation in breast cancer
Preetha J. Shetty et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
β-Actin specifically controls cell growth, migration, and the G-actin pool
Tina M. Bunnell et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Reversible Ponceau staining as a loading control alternative to actin in Western blots
Isabel Romero-Calvo et al.
ANALYTICAL BIOCHEMISTRY (2010)
Genome-wide identification of new imprinted genes
Amandine Henckel et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2010)
Dairy intake associates with the IGF rs680 polymorphism to height variation in periadolescent children
G. V. Dedoussis et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2010)
Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women
S. Kalla Singh et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Differential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparity
S. Kalla Singh et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin
Gamze Gokoz Dogu et al.
MEDICAL ONCOLOGY (2010)
Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray
Daron J. Williams et al.
HUMAN PATHOLOGY (2009)
IGF and Insulin Receptor Signaling in Breast Cancer
Antonino Belfiore et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2008)
Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells
S. Kalla Singh et al.
GROWTH FACTORS (2007)
Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women
David P. Rose et al.
ENDOCRINE REVIEWS (2007)
IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells
C. M. Perks et al.
ONCOGENE (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
IGF-II gene region polymorphisms related to exertional muscle damage
Joseph M. Devaney et al.
JOURNAL OF APPLIED PHYSIOLOGY (2007)
Triple-negative breast cancer: therapeutic options
Susan Cleator et al.
LANCET ONCOLOGY (2007)
β-Actin is not a reliable loading control in Western blot analysis
Angela Dittmer et al.
ELECTROPHORESIS (2006)
Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human
D Monk et al.
HUMAN MOLECULAR GENETICS (2006)
Down-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes
ZH Chen et al.
BMC CELL BIOLOGY (2004)
Insulin-like growth factor (IGF)-I and IGF-II serum concentrations in patients with benign and malignant breast lesions: free IGF-II is correlated with breast cancer size
CF Singer et al.
CLINICAL CANCER RESEARCH (2004)
Low circulating IGF-II concentrations predict weight gain and obesity in humans
MJS Sandhu et al.
DIABETES (2003)
Interactions between insulin-like growth factor estrogen and signaling pathways in human breast tumor cells
IHL Hamelers et al.
ENDOCRINE-RELATED CANCER (2003)
Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer
CK Osborne et al.
BREAST (2003)
IGF-2 is a mediator of prolactin-induced morphogenesis in the breast
C Brisken et al.
DEVELOPMENTAL CELL (2002)
Placental-specific IGF-II is a major modulator of placental and fetal growth
M Constância et al.
NATURE (2002)
Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet β-cells and enhances insulin secretion
CM Buchanan et al.
BIOCHEMICAL JOURNAL (2001)
Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor
JD Ravenel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Steroids and the endometrium
MK Oehler et al.
CURRENT MEDICINAL CHEMISTRY (2000)
Transgenic mice overexpressing insulin-like growth factor-II in β cells develop type 2 diabetes
JC Devedjian et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)